pembrolizumab
merck
['kn-716', 'melanoma']
excited for #melanoma oral abstracts this morning at #asco22. looking for info to take into clinic next week. first up, discussing updates on kn-716. evolving area for the melanoma community as there has not prev been role for med onc care for stage iib/c pts. 
Med onc at UW/SCCA/Fred Hutch focused on melanoma and RCC, interested in patient/caregiver QOL and all things immunotherapy. All opinions are my own.